Results 101 to 110 of about 1,329 (197)

Chronic pain education: past, present, and future of psychedelics for the management of chronic pain. [PDF]

Pain Med
Robinson CL, Solanki PK, Snyder S, Amir A, Barreveld A, Mather RV, Cerda IH, Motoc M, Chopra H, Yong RJ, Castellanos J, Furnish T, Kaye AD, Orhurhu V, Emerick T.   +14 more
europepmc   +1 more source

"Selective" serotonin 5-HT_2A receptor antagonists. [PDF]

Biochem Pharmacol, 2022
Casey AB, Cui M, Booth RG, Canal CE.
europepmc   +1 more source

OTsENKA EFEKTIVNOSTI REABILITATsII BOL'NYKh PERENESShIKh KRUPNOOChAGOVYY INFARKT MIOKARDA PRI ISPOL'ZOVANII KARDIOREABILITATsIONNOY SISTEMY ERGOLINE NA SANATORNOM ETAPE LEChENIYa

, 2011
T. Yu. Glotova, А. Н. Гончаров
openalex   +1 more source

Cabergoline-induced cerebrospinal fluid fistulae in macroprolactinomas. [PDF]

Langenbecks Arch Surg
Hermann EJ, Hertz S, Nakamura M, Terkamp C, Kinfe TM, Stolle S, Leitolf H, Fahlbusch R, Krauss JK.   +8 more
europepmc   +1 more source

Antihypertensive effects of a novel ergoline derivative, BAM-1101

, 1986
Kenji Ichihara, Mitsuaki Nagasaka, Keiichi Okumura, T.A. Ban, Hajime Asai   +4 more
openalex   +1 more source

Ethical Considerations Regarding Psychedelics for Clinical Pain Research. [PDF]

J Pain Res
Robinson CL, Slitzky M, Schatman ME, Yong RJ, Lehman AD, Kaynar AM, Shivanekar SP, Emerick T.   +7 more
europepmc   +1 more source

Antihypertensive effect of a novel ergoline derivative, BAM-2101

, 1987
Mitsuaki Nagasaka, Keiichi Okumura, Kenji Ichihara, T.A. Ban, Hajime Asai   +4 more
openalex   +1 more source

[Efficacy of standard methods in the treatment of prolactin-secreting pituitary carcinoma]. [PDF]

Probl Endokrinol (Mosk)
Astafyeva LI, Kalinin PL, Trunin YY, Kobyakov GL, Sidneva YG.   +4 more
europepmc   +1 more source

μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges. [PDF]

Front Pharmacol, 2023
Salinsky LM, Merritt CR, Zamora JC, Giacomini JL, Anastasio NC, Cunningham KA.   +5 more
europepmc   +1 more source

Synthesis and Structure-Activity Relationships of New (5R,8S,10R)-Ergoline Derivatives with Antihypertensive or Dopaminergic Activity.

, 1994
Sachio Ohno, Masayuki KOUMORI, Yuko ADACHI, Kiyoshi Mizukoshi, Mitsuaki Nagasaka, Kenji Ichihara   +5 more
openalex   +2 more sources